2024-06-14 15:15:06 ET
2024-06-14 15:15:06 ET
Market Wire News is a media platform, the information on this page was provided by KlickAnalytics via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / June 19, 2024 / Gilead Sciences Gilead and Kite Pharma teams raised Pride Month flags at our campuses last week symbolizing our united support for LGBTQ+ communities globally. Our commitment to inclusion and diversity is vital to our mission and will help us cre...
Magrolimab was the centerpiece of Gilead Sciences Inc's (NASDAQ:GILD) $4.9 billion buyout of Forty Seven Inc in March 2020. Magrolimab is a mo...
2024-06-14 15:15:06 ET RBC Capital analyst issues UNDERPERFORM recommendation for GILD on June 14, 2024 12:00PM ET. The previous analyst recommendation was Underperform. GILD was trading at $65.16 at issue of the analyst recommendation. The overall analyst consensus : BU...